Gast ::
| Hauptseite > Publikationsdatenbank > Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas > print |
| Hauptseite > Publikationsdatenbank > Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas > print |
| 001 | 909634 | ||
| 005 | 20230301073204.0 | ||
| 024 | 7 | _ | |a 10.1007/s11060-022-04066-9 |2 doi |
| 024 | 7 | _ | |a 0167-594X |2 ISSN |
| 024 | 7 | _ | |a 1573-7373 |2 ISSN |
| 024 | 7 | _ | |a 2128/31832 |2 Handle |
| 024 | 7 | _ | |a 35716310 |2 pmid |
| 024 | 7 | _ | |a WOS:000812617800002 |2 WOS |
| 037 | _ | _ | |a FZJ-2022-03305 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Werner, Jan-Michael |b 0 |
| 245 | _ | _ | |a Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas |
| 260 | _ | _ | |a Dordrecht [u.a.] |c 2022 |b Springer Science + Business Media B.V |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1662718688_21071 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 536 | _ | _ | |a 5252 - Brain Dysfunction and Plasticity (POF4-525) |0 G:(DE-HGF)POF4-5252 |c POF4-525 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to DataCite |
| 700 | 1 | _ | |a Wolf, Lena |b 1 |
| 700 | 1 | _ | |a Tscherpel, Caroline |b 2 |
| 700 | 1 | _ | |a Bauer, Elena K. |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Wollring, Michael |0 P:(DE-Juel1)190394 |b 4 |
| 700 | 1 | _ | |a Ceccon, Garry |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Deckert, Martina |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Brunn, Anna |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Pappesch, Roberto |b 8 |
| 700 | 1 | _ | |a Goldbrunner, Roland |b 9 |
| 700 | 1 | _ | |a Fink, Gereon R. |0 P:(DE-Juel1)131720 |b 10 |
| 700 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 11 |e Corresponding author |
| 773 | _ | _ | |a 10.1007/s11060-022-04066-9 |g Vol. 159, no. 2, p. 309 - 317 |0 PERI:(DE-600)2007293-4 |n 2 |p 309 - 317 |t Journal of neuro-oncology |v 159 |y 2022 |x 0167-594X |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/909634/files/FINK_Werner_2022_Journal%20of%20Neuro%20Oncology_Efficacy%20and%20tolerability%20of%20regorafenib%20in%20pretreated%20patients%20with%20progessive%20CNS%20grade%203%20or%204%20gliomas.pdf |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:909634 |p openaire |p open_access |p OpenAPC_DEAL |p driver |p VDB |p openCost |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)190394 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 10 |6 P:(DE-Juel1)131720 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 11 |6 P:(DE-Juel1)143792 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5252 |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-28 |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2021-01-28 |w ger |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-28 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-08 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-08 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEURO-ONCOL : 2021 |d 2022-11-08 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2022-11-08 |
| 915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
| 915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
| 915 | p | c | |a DFG OA Publikationskosten |2 APC |0 PC:(DE-HGF)0002 |
| 915 | p | c | |a DEAL: Springer Nature 2020 |2 APC |0 PC:(DE-HGF)0113 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 980 | 1 | _ | |a FullTexts |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | _ | _ | |a APC |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|